Back to search
Advanced Malignancies and Hepatic Impairment
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Malignancies and Hepatic Impairment trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Malignancies and Hepatic Impairment trials you may qualify forThe goals of this clinical study are to learn more about the safety and dosing of the study drug, sacituzumab govitecan-hziy, in participants with solid tumors…
This purpose of this study is to help to evaluate the pharmacokinetic (PK) profile of pralatrexate when administered to patients with various degrees of hepatic…
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the safety and efficacy o…
This main aim of this trial will be to study the blood levels (known as pharmacokinetics) of the study drug tazemetostat. The pharmacokinetics of the study dru…
The primary purpose of this study is to evaluate the impact of hepatic function on the pharmacokinetic (PK) profile of pelabresib in participants with advanced…